New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 1, 2023 - Viatris launched an AB-rated generic version of AstraZeneca’s Onglyza (saxagliptin) tablets.
Download PDF
Return to publications
